Manufacturing channel feed

Ther­mo Fish­er plat­form seeks to ex­pe­dite donor cell cul­ti­va­tion for al­lo­gene­ic cell ther­a­pies

6 minutes ago

Psy­che­del­ic biotech ATAI hopes to ex­pand port­fo­lio through re­search part­ner­ship with Mass Gen­er­al

23 hours ago

Vir's CMO says he's sur­prised that a low dose of their he­pati­tis B drug ap­pears promis­ing in ear­ly slice of da­ta — shares soar

Yesterday

Lon­za look­ing to build on 'd­if­fer­en­ti­at­ed ad­van­tage' in Covid-19, CD­MO mar­ket­place in 2021

2 days ago
Pharma

Flush with cash to change the gener­ics sup­ply chain, Civi­ca Rx looks to break ground on first in-house man­u­fac­tur­ing site

5 days ago

North­way Biotech sets up shop in Boston hub, look­ing to court more cus­tomers with bi­o­log­ics-fo­cused plant

6 days ago

Lon­za hits the ex­it on gel and liq­uid cap­sules, of­fload­ing 2 pro­duc­tion sites to NextPhar­ma

Last week
Deals

Cog­nate dou­bles man­u­fac­tur­ing ca­pac­i­ties in Mem­phis, Eu­rope, as de­mand for cell and gene ther­a­pies sky­rock­ets

Last week
Cell/Gene Tx

Look­ing to build in red-hot vi­ral vec­tor space, Ther­mo Fish­er inks $878M deal for Bel­gian man­u­fac­tur­er's 2 plants

Last week
Deals

Fu­ji­film dou­bles down on Boston foothold, rent­ing some ma­jor legroom to chase cell and gene ther­a­pies

2 weeks ago
Financing

Acor­da of­floads man­u­fac­tur­ing op­er­a­tions to Catal­ent for $70M amid lat­est re­struc­tur­ing to keep the ship afloat

2 weeks ago
Deals

Adap­ti­m­mune 'ready for prime­time' as it pre­pares to launch T cell ther­a­py for sar­co­ma, CEO Adri­an Raw­cliffe says

3 weeks ago
Cell/Gene Tx

Abzena plots 6th bi­o­log­ics plant as de­mand for mam­malian cell-line pro­duc­tion con­tin­ues to grow

3 weeks ago

Once aim­ing to dou­ble on­col­o­gy pipeline, Servier's US branch touts rapid pace in build­ing its foothold in the space

3 weeks ago

Boehringer In­gel­heim per­ma­nent­ly shelves pro­duc­tion of cloni­dine, cit­ing ear­li­er re­call and mar­ket com­peti­tors

3 weeks ago
Regulatory

Af­ter ear­ly hic­cups in man­u­fac­tur­ing, Ad­verum out­lines plans for com­mer­cial gene ther­a­py plant in North Car­oli­na hub

3 weeks ago

Mer­ck KGaA snaps up Ger­man CD­MO in boost to mR­NA port­fo­lio — in­clud­ing for Covid-19

3 weeks ago
Deals

Mod­er­na inks deal for over­seas Covid-19 vac­cine fin­ish­ing work as Eu­ro­pean ap­proval hangs in bal­ance

4 weeks ago
Coronavirus

On­corus plots ear­ly-stage plant in Boston area as it walks I-O can­di­date through the clin­ic

4 weeks ago

Fast-ex­pand­ing Shang­hai Phar­ma breaks ground on $1.8B biotech park fo­cused on next-gen R&D, an­ti­body pro­duc­tion

4 weeks ago
China

Am­gen hands off rights to lep­rosy, tu­ber­cu­lo­sis med picked up as part of $13.4B Ote­zla deal

Last month
Deals

Twist Bio­sciences plots its 'fac­to­ry of the fu­ture' in Ore­gon, seeks to ex­pand syn­thet­ic DNA client base

Last month
Pharma

Amid a busy year and new lead­er­ship, Lon­za looks to build bio­con­ju­gates ca­pac­i­ty with Swiss ex­pan­sion set for 2022

Last month
Outsourcing

FDA stiff arms No­var­tis in a sur­prise set­back for their PC­SK9 drug in­clisir­an

Last month
Regulatory
12 Next page Last page